Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (211-220 of 550) with videos related to

Pageof 55
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Dendritic cell infiltration and prognosis of early stage breast cancerIsabelle Treilleux, Jean-Yves Blay, Nathalie Bendriss-Vermare, et al.
Frontiers in Oncology|November 28, 2022
Expanding the molecular spectrum of tenosynovial giant cell tumorsThibault Gauduchon, Helene Vanacker, Daniel Pissaloux, et al.
NPJ Digital Medicine|June 20, 2026
Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancerJean-Sébastien Frenel, Pierre-Etienne Heudel, Emmanuelle Guinaudeau, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2026
Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohortClio Coste, Mehdi Brahmi, Franck Tirode, et al.
BMC Cancer|February 18, 2011
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trialAurore Blesius, Philippe A Cassier, François Bertucci, et al.
BMC Cancer|April 21, 2010
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes regionAntoine Lurkin, Francoise Ducimetière, Dominique Ranchère Vince, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovaryNicholas Simon Reed, Eva Gomez-Garcia, Dolores Gallardo-Rincon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcomaFrédéric Amant, Anne Floquet, Michael Friedlander, et al.
Clinical Sarcoma Research|September 7, 2012
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patientsFlorence Duffaud, Caroline Even, Isabelle Ray-Coquard, et al.
Bulletin Du Cancer|January 31, 2008
[Imatinib and solid tumours]Samia Arifi, Hiba El Sayadi, Armelle Dufresne, et al.
Pageof 55

Showing results (211-220 of 550) with videos related to

Sort By:
Pageof 55
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Dendritic cell infiltration and prognosis of early stage breast cancerIsabelle Treilleux, Jean-Yves Blay, Nathalie Bendriss-Vermare, et al.
Frontiers in Oncology|November 28, 2022
Expanding the molecular spectrum of tenosynovial giant cell tumorsThibault Gauduchon, Helene Vanacker, Daniel Pissaloux, et al.
NPJ Digital Medicine|June 20, 2026
Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancerJean-Sébastien Frenel, Pierre-Etienne Heudel, Emmanuelle Guinaudeau, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2026
Clinical determinants, diagnostic complexity, and molecular heterogeneity in NF1-associated and sporadic malignant peripheral nerve sheath tumors: A 25-year referral-center cohortClio Coste, Mehdi Brahmi, Franck Tirode, et al.
BMC Cancer|February 18, 2011
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trialAurore Blesius, Philippe A Cassier, François Bertucci, et al.
BMC Cancer|April 21, 2010
Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes regionAntoine Lurkin, Francoise Ducimetière, Dominique Ranchère Vince, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovaryNicholas Simon Reed, Eva Gomez-Garcia, Dolores Gallardo-Rincon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 18, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcomaFrédéric Amant, Anne Floquet, Michael Friedlander, et al.
Clinical Sarcoma Research|September 7, 2012
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patientsFlorence Duffaud, Caroline Even, Isabelle Ray-Coquard, et al.
Bulletin Du Cancer|January 31, 2008
[Imatinib and solid tumours]Samia Arifi, Hiba El Sayadi, Armelle Dufresne, et al.
Pageof 55